Cargando…

Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance

BACKGROUND: The link between cholesterol and Alzheimer’s disease (AD) has received much attention, as evidence suggests high levels of cholesterol might be an AD risk factor. The carriage of cholesterol and lipids through the body is mediated via lipoproteins, some of which, particularly apolipoprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedrini, Steve, Hone, Eugene, Gupta, Veer B., James, Ian, Teimouri, Elham, Bush, Ashley I., Rowe, Christopher C., Villemagne, Victor L., Ames, David, Masters, Colin L., Rainey-Smith, Stephanie, Verdile, Giuseppe, Sohrabi, Hamid R., Raida, Manfred R., Wenk, Markus R., Taddei, Kevin, Chatterjee, Pratishtha, Martins, Ian, Laws, Simon M., Martins, Ralph N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592676/ https://www.ncbi.nlm.nih.gov/pubmed/32741823 http://dx.doi.org/10.3233/JAD-200291

Ejemplares similares

Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume
por: Pedrini, Steve, et al.
Publicado: (2022)

The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults
por: Pedrini, Steve, et al.
Publicado: (2022)

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
por: Gupta, Veer Bala, et al.
Publicado: (2015)

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
por: Pedrini, Steve, et al.
Publicado: (2017)

Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort
por: Gupta, Veer Bala, et al.
Publicado: (2017)

Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies
por: Martins, Ralph N., et al.
Publicado: (2018)

Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort
por: Gupta, Veer B, et al.
Publicado: (2015)

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults
por: Porter, Tenielle, et al.
Publicado: (2019)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
por: Porter, Tenielle, et al.
Publicado: (2018)

Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer’s Disease
por: Lim, Wei Ling Florence, et al.
Publicado: (2020)

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Plasma Glial Fibrillary Acidic Protein Is Associated with (18)F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer’s Disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2023)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
por: Porter, Tenielle, et al.
Publicado: (2018)

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
por: Fernandez, Shane, et al.
Publicado: (2021)

Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months
por: Thai, Christine, et al.
Publicado: (2015)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
por: Gardener, Samantha L., et al.
Publicado: (2021)

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
por: Frost, S, et al.
Publicado: (2013)

Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry
por: Frost, Shaun, et al.
Publicado: (2017)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

Intense physical activity is associated with cognitive performance in the elderly
por: Brown, B M, et al.
Publicado: (2012)

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
por: Dhiman, Kunal, et al.
Publicado: (2020)

Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology
por: Ashraf, Azhaar, et al.
Publicado: (2020)

Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease
por: Hata, Saori, et al.
Publicado: (2019)

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2021)

Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study
por: Lim, Yen Ying, et al.
Publicado: (2014)

Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
por: Dhiman, Kunal, et al.
Publicado: (2022)

Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults
por: Gardener, Samantha L., et al.
Publicado: (2021)

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
por: Harrington, Karra D., et al.
Publicado: (2017)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
por: Huynh, Kevin, et al.
Publicado: (2020)

Relationship between subclasses low-density lipoprotein and carotid plaque
por: Pan, Zhanhai, et al.
Publicado: (2022)

Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
por: Laws, Simon M., et al.
Publicado: (2017)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals
por: Dhiman, Kunal, et al.
Publicado: (2022)

Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance
por: Dang, Christa, et al.
Publicado: (2019)

Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health
por: Streese, Lukas, et al.
Publicado: (2022)

Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
por: Goozee, Kathryn, et al.
Publicado: (2017)

Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults
por: Thota, Rohith N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mu4n1rvdg42h2ahjd19ubstkmm